Jason Westin, MD FACP FASCO
@Lymphoma_Doc
Followers
8K
Following
8K
Media
449
Statuses
8K
Professor @MDAndersonNews, Lead of Lymphoma/Myeloma Service Line, Director of Clinical Research, Section Chief of Aggressive/Indolent Lymphomas, Opinions mine
Houston, TX
Joined January 2013
I am so honored to receive the @ASCO Advocate of the Year award. Engaging with advocacy is such an important way to support our patients. #ASCOAdvocacySummit
“If we're not advocating…fighting against #drugshortages & for NCI funding & the CONNECT for Health Act, others are advocating the other direction...What you're doing here really matters,” Advocate of the Year @lymphoma_doc. Congrats! https://t.co/UiVKrQNLXc
#ASCOAdvocacySummit
28
15
214
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-cell Lymphoma: Primary Results of the Phase 3 SUNMO Trial. Co-authored by @Lymphoma_Doc Read the full article https://t.co/StBnyQQXA0
#lymsm
ascopubs.org
PURPOSEPrognosis for patients with refractory/relapsed large B-cell lymphoma (LBCL) considered ineligible for curative-intent therapy is poor. The combination of mosunetuzumab, a T-cell–engaging...
0
3
23
The SUNMO trial manuscript is now published at @JCO_ASCO! Mosun-Pola is superior to RGemOx in patients with ref/rel LBCL with 3X progression free survival and 2x complete response rates. Only 4% had CRS more than a fever. #lymsm
@elizabeth_budde
https://t.co/7u02KikJmE
ascopubs.org
PURPOSEPrognosis for patients with refractory/relapsed large B-cell lymphoma (LBCL) considered ineligible for curative-intent therapy is poor. The combination of mosunetuzumab, a T-cell–engaging...
4
20
78
America’s legacy of advances in cancer, powered by fed research funding, transformed care & saved countless lives. Our legacy is a light of hope for patients & families. We must not abandon it. #SaveResearchStopCancer #ASCOAdvocacy Take action with us: https://t.co/7BbbjQhVKR
0
2
9
With 3,000 patients, 260 sites in the last 9 years, @ASCO is seeking a Scientific PI for the unique #TAPUR Clinical trial: https://t.co/NSqPcfvyY3
1
16
41
50 years ago, surviving cancer was a rarity. Federally funded research changed that for millions of Americans. But progress is now at risk. Unstable funding threatens to halt future breakthroughs. #SaveResearchStopCancer #ASCOAdvocacy Take action with us: https://t.co/hgEl0p3DPr
2
20
36
Cancer treatments remain vulnerable to #drugshortages in the U.S. #ASCOAdvocacy Urge your lawmakers to take action to help secure the pharmaceutical pipeline and address this crisis:
asco.quorum.us
Ask your lawmakers to take steps to mitigate drug shortages.
"Tariffs threaten to hit medicines like antibiotics particularly hard. They have very thin profit margins, they are vulnerable to shortages and U.S. production is very limited." The USP Medicine Supply Map helped @nytimes visualize how medicines reach American shelves:
1
9
18
An excellent session for our patients and their caregivers to empower them as they navigate their disease journey! I will be presenting on extranodal and 🧠🧠 lymphoma @MDAndersonNews @lymphomahub @LymphomaAction @WomenInLymphoma @HemOncWomenDocs @lymphoma
Join us at our Virtual Educational Forum, coming up September 20-21 to learn the latest in lymphoma from the experts, including deep dives at disease-specific breakout sessions as well as special sessions on the topics you'll want to learn more about: https://t.co/bTEtpUBw19.
1
6
19
America’s legacy of advances in cancer, powered by fed research funding, transformed care & saved countless lives. Our legacy is a light of hope for patients & families. We must not abandon it. #SaveResearchStopCancer #ASCOAdvocacy Take action with us: https://t.co/7BbbjQhVKR
1
13
22
Grateful for the opportunity to serve on the @ASCO Board of Directors. Looking forward to contributing to the mission of conquering cancer through research, education, and promotion of the highest quality patient care. https://t.co/2UJ5tOEsqa
connection.asco.org
ASCO is pleased to welcome Dr. Jason Westin to the Society Board of Directors. Dr. Westin is filling a seat vacated by Dr. Nathan Pennell, who stepped down after accepting a new employment opportunity
24
13
146
ASCO works to shape health policy to improve #cancer treatment & pt access to care. What policies should we develop or update next? Let us know using our topic submission form: https://t.co/CtF8u4OmeA
2
6
12
If you’re interested in taking that next step toward leadership, a quick reminder that applications for our Leadership Development Program are open through September 22. Learn more & apply today: https://t.co/5ZYkWmEUG0
0
16
38
Just came on board as host of the #ASCODailyNews Podcast - and what a terrific way to kick things off! Had a great conversation with @KimmieNgMD @DanaFarber about the pressing topic of #earlyonset #colorectalcancer. Click 👇to🎧: https://t.co/d9a4amvIo5
1
21
63
Congratulations to our CMO Dr. @jrgralow on receiving the 2025 @CancerGridIndia Lifetime Achievement Award in Oncology! The award was presented at the NCG Annual Meeting in Mumbai, India, for her longstanding contributions to cancer care, research, and global oncology.
7
11
55
Drs. @DebSiegal & @Lymphoma_Doc giving a great talk this morning about how to run a research team at @ASH_hematology CRTI. #ASHKudos
0
1
27
Thank you @AppropsGOP @SenateApprops for your bipartisan support to increase funding for @NIH & @theNCI in the FY26 LHHS appropriations bill. #CancerResearch saves lives. #ASCOAdvocacy Read our full statement: https://t.co/dT9kiPXRKw
0
10
21
The August 1 deadline for submitting your topic suggestions or new evidence for an existing guideline is almost here. This is a crucial opportunity to contribute your expertise and help set the standards for future cancer care. Submit today: https://t.co/CVlqDJGmTt
0
5
9
Investing in #CancerResearch saves lives! Urge your lawmakers to support FY26 funding for @NIH & @theNCI, ahead of @SenateApprops @AppropsGOP meeting on the LHHS spending bill. #ASCOAdvocacy Act now: https://t.co/6WZBRvPzBB
0
9
16
MD Anderson is proud to be named #1 in the nation for cancer care in @USNews’“Best Hospitals” ranking. Read more: https://t.co/6DKYn4XAp5
#BestHospitals #EndCancer
10
63
211
What an honor for @MDAndersonNews to again be #1 in the nation in cancer care, according to @USNews. I am deeply appreciative of everyone in our MD Anderson community: each of you played a role in this extraordinary accomplishment as we work together to #EndCancer.
MD Anderson is proud to be named #1 in the nation for cancer care in @USNews’“Best Hospitals” ranking. Read more: https://t.co/6DKYn4XAp5
#BestHospitals #EndCancer
8
24
133
In addition to the outstanding professional development offered, LDP participants (and their mentors) become friends and colleagues for life! The application period for the 2026-27 LDP is open through Sept. 22. See below for details.
Connect w/ peers who share your interest in building leadership skills & participate in what could be, as @montypal considers it, “one of the most gratifying experiences of [your] career”: the ASCO Leadership Development Program. Applications now open! https://t.co/d6KWd49X1v
0
9
43